Try our beta test site
Trial record 1 of 1 for:    NovoCure EF-14
Previous Study | Return to List | Next Study

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
NovoCure Ltd.
ClinicalTrials.gov Identifier:
NCT00916409
First received: June 5, 2009
Last updated: October 16, 2016
Last verified: October 2016